Omnicell, Inc. (OMCL)

NasdaqGS · Health Information Services

35.99
-0.05 (-0.13%)
Updated Aug 18, 5:45 PM ET
AI Rating
Sell
Overall Score
30
Trend
28
Momentum
20
Risk
46

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Omnicell, Inc. is trading at $35.99, down 0.13% on the session. The 50 day average sits at $40.80 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 41.6, which reads as weak, and MACD is bearish crossover. Volume is below average.

The nearest support is around $36.55 with resistance near $38.00, so that band frames the current range. Average daily movement is roughly $1.74, or about 4.8% of the share price, which is what any stop placement has to allow for. The overall health score of 30 out of 100 combines a trend score of 28, momentum of 20 and a risk score of 46.

Technical indicators

RSI (14)
41.6
weak
MACD
-1.451
bearish crossover
SMA 20
38.92
SMA 50
40.80
SMA 200
--
unknown
ATR (14)
1.74
avg daily range
Support
36.55
Resistance
38.00
Volume vs 20d
0.45x
below average
Volatility
62.2%
annualised
1 month
-20.64%
3 months
-14.84%

About Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.